Detalhe da pesquisa
1.
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy.
Genes Dev
; 31(6): 553-566, 2017 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28404630
2.
The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options.
Cell Oncol (Dordr)
; 46(3): 603-628, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36598637
3.
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer.
Nat Cancer
; 4(2): 257-275, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36585452
4.
In vitro modeling of hepatocellular carcinoma molecular subtypes for anti-cancer drug assessment.
Exp Mol Med
; 50(1): e419, 2018 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29303513
5.
Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRß2) splice variant in breast cancer.
Oncotarget
; 7(30): 47201-47220, 2016 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27363015